| Heart disease and stroke statistics—2015 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 131 (4), e29-e322, 2015 | 52510* | 2015 |
| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study S Yusuf, S Hawken, S Ôunpuu, T Dans, A Avezum, F Lanas, M McQueen, ... The lancet 364 (9438), 937-952, 2004 | 18389* | 2004 |
| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Antithrombotic Trialists' Collaboration Bmj 324 (7329), 71-86, 2002 | 12297* | 2002 |
| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England Journal of Medicine 361 (12), 1139-1151, 2009 | 12210 | 2009 |
| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators New England Journal of Medicine 345 (7), 494-502, 2001 | 7947 | 2001 |
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. S Yusuf, P Sleight, J Pogue, J Bosch, R Davies, G Dagenais The New England journal of medicine 342 (3), 145-153, 2000 | 7837 | 2000 |
| 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed … Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ... European heart journal 33 (21), 2719-2747, 2012 | 6107 | 2012 |
| Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study SR Mehta, S Yusuf, RJG Peters, ME Bertrand, BS Lewis, MK Natarajan, ... The Lancet 358 (9281), 527-533, 2001 | 4210 | 2001 |
| Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions SOLVD Investigators* New England Journal of Medicine 327 (10), 685-691, 1992 | 4027 | 1992 |
| Beta blockade during and after myocardial infarction: an overview of the randomized trials S Yusuf, R Peto, J Lewis, R Collins, P Sleight Progress in cardiovascular diseases 27 (5), 335-371, 1985 | 3883 | 1985 |
| Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. C Baigent, L Blackwell, J Emberson, LE Holland, C Reith, N Bhala, R Peto, ... Lancet (London, England) 376 (9753), 1670-1681, 2010 | 3757 | 2010 |
| Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Heart Outcomes Prevention Evaluation (HOPE) Study Investigators The lancet 355 (9200), 253-259, 2000 | 3672 | 2000 |
| Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study S Yusuf, S Hawken, S Ounpuu, L Bautista, MG Franzosi, P Commerford, ... The Lancet 366 (9497), 1640-1649, 2005 | 3473 | 2005 |
| Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study MJ O'donnell, D Xavier, L Liu, H Zhang, SL Chin, P Rao-Melacini, ... The Lancet 376 (9735), 112-123, 2010 | 3449 | 2010 |
| Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial S Yusuf, MA Pfeffer, K Swedberg, CB Granger, P Held, JJV McMurray, ... The Lancet 362 (9386), 777-781, 2003 | 3151 | 2003 |
| The effect of digoxin on mortality and morbidity in patients with heart failure Digitalis Investigation Group New England Journal of Medicine 336 (8), 525-533, 1997 | 3119 | 1997 |
| Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events … HG Site Lancet 367 (9526), 1903-1912, 2006 | 2894* | 2006 |
| Apixaban in patients with atrial fibrillation SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ... New England Journal of Medicine 364 (9), 806-817, 2011 | 2888 | 2011 |
| Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals HC Gerstein, JFE Mann, Q Yi, B Zinman, SF Dinneen, B Hoogwerf, ... Jama 286 (4), 421-426, 2001 | 2886 | 2001 |
| Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study A Rosengren, S Hawken, S Ôunpuu, K Sliwa, M Zubaid, WA Almahmeed, ... The Lancet 364 (9438), 953-962, 2004 | 2682 | 2004 |
